When I tried to buy a backup bottle from London Drugs and Shoppers Drug Mart, it was sold out EVERYWHERE! I think I went to most of the store locations within my neighbouring cities, and everyone was backordered. Who knew it was the hottest thing ...
Transcatheter arterial chemoembolization (also called transarterial chemoembolization or TACE) is a minimally invasive procedure performed in interventional radiology to restrict a tumors blood supply. Small embolic particles coated with chemotherapeutic drugs are injected selectively through a catheter into an artery directly supplying the tumor. These particles both block the blood supply and induce cytotoxicity, attacking the tumor in several ways. The radiotherapeutic analogue (combining radiotherapy with embolization) is called radioembolization or selective internal radiation therapy (SIRT). TACE derives its beneficial effect by two primary mechanisms. Most tumors within the liver are supplied by the proper hepatic artery, so arterial embolization preferentially interrupts the tumors blood supply and stalls growth until neovascularization. Secondly, focused administration of chemotherapy allows for delivery of a higher dose to the tissue while simultaneously reducing systemic exposure, ...
Lipiodol (labeled Ethiodol in the USA), also known as ethiodized oil, is a poppyseed oil used by injection as a radio-opaque contrast agent that is used to outline structures in radiological investigations. It is used in chemoembolization applications as a contrast agent in follow-up imaging. Lipiodol is also used in lymphangiography, the imaging of the lymphatic system. It has an additional use in gastric variceal obliteration as a dilutant that does not affect polymerization of cyanoacrylate. Recently there has been an increasing interest in the use of Lipiodol as a therapeutic agent in the management of unexplained infertility, using a procedure called Lipiodol flushing. There have been a small number of studies that suggest that flushing the media through the tubes gives a short-term rise in fecundity in patients with unexplained infertility. A systematic review has suggested a significant increase in fertility, especially in those women who have endometriosis when using Lipiodol flushing. ...
PATIENTS. Ninety-two patients underwent extended right-sided hepatic resection for hepatobiliary malignancy during a 45-month period (January 2000 to September 2003). Among them, 15 (16%) underwent portal vein embolisation via a percutaneous ipsilateral approach (n=9) or through the ileocolic vein with a mini-laparotomy (n=6). The remaining 77 (84%) patients underwent hepatic resection without portal vein embolisation ...
Fingerprint Dive into the research topics of Efficacy of oral iodized peanut oil is greater than that of iodized poppy seed oil among Indonesian schoolchildren. Together they form a unique fingerprint. ...
Arm E: Suspension is prepared before arterial infusion as follows: Epirubicin is dissolved with water-soluble, non-ionized contrast medium then mixed with Lipiodol by pumping. Then this suspension is administered by catheter as quick as possible, and gelatin is infused for arterial embolization. Maximum dose of EPI and Lipiodol are 60mg/m2 and 0.3mL/Kg, respectively ...
Clinical trial focusing on transarterial chemoembolization. Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer
Chemoembolisation is a treatment used for cancer that starts in the liver, or cancer that has spread to the liver from somewhere else in the body.
Using palliative transarterial chemoembolization (TACE) a reduction of malignant liver neoplasms and a prolongation of survival time can be achieved. During the course of therapy phosphorous magnetic resonance spectroscopy by means of chemical-shift-imaging was used for noninvasive examination of the cellular metabolism of energy and membranes. Differentiation between primary and secondary liver tumors was not feasible using 31P-spectra. After therapy patients had shown increased inorganic phosphate signal and reduction of the ß-NTP-signals, which normalized during six week intervall before next intervention. Response and non-response to therapy showed different courses of spectroscopic quotients during therapy cycle. Prominent reduction of volume as well as homogeneous and continous retention of lipiodol within the tumor are reliable combined with spectroscopic response to therapy. The first group of patients showed these signs at the examination immediately after embolization whereas patients ...
The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy. ...
Detailed dosage guidelines and administration information for Lipiodol (ethiodized oil). Includes dose adjustments, warnings and precautions.
TY - JOUR. T1 - A case of hepatocellular carcinoma with skin injury of the upper abdominal wall after transcatheter arterial chemoembolization. T2 - A case report. AU - Kanzaki, Hiromitsu. AU - Nouso, Kazuhiro. AU - Miyahara, Koji. AU - Kajikawa, Naoko. AU - Kobayashi, Sayo. AU - Sakakihara, Ichiro. AU - Iwadow, Shota. AU - Uematsu, Shuji. AU - Okamoto, Ryoichi. AU - Shiraga, Kunihiro. AU - Mizuno, Motowo. AU - Araki, Yasuyuki. PY - 2009/9/1. Y1 - 2009/9/1. N2 - Introduction: Transcatheter arterial chemoembolization has been widely used to treat advanced hepatocellular carcinoma that cannot be treated by local ablation therapies or surgical resection. The effectiveness of transcatheter arterial chemoembolization in prolonging survival has been well established, and approximately one third of newly discovered hepatocellular carcinoma patients were repeatedly treated by transcatheter arterial chemoembolization in Japan. Various kinds of complications have been reported, and many of which are ...
TY - JOUR. T1 - Evaluation of Hepatocellular Carcinoma Tumor Response After Transcatheter Arterial Chemoembolization Using Gadobenate Dimeglumine-Enhanced Liver Magnetic Resonance. AU - Chu, Linda Chi Hang. AU - Pozzessere, Chiara. AU - Corona Villalobos, Celia. AU - Castaños, Sandra. AU - Rastegar, Neda. AU - Halappa, Vivek. AU - Bonekamp, Susanne. AU - Emurano, Emi. AU - Kamel, Ihab R. PY - 2016/9/27. Y1 - 2016/9/27. N2 - OBJECTIVE: Use of gadobenate dimeglumine-enhanced liver magnetic resonance (MR) for evaluation of hepatocellular carcinoma tumor response after transcatheter arterial chemoembolization (TACE). METHODS: Forty-five patients with hepatocellular carcinoma were imaged with multiphase gadobenate dimeglumine-enhanced MR examination at baseline and 1-month follow-up after TACE. Nodule size, enhancement, and apparent diffusion coefficient were measured for both examinations by 2 reviewers. Changes in tumor nodule size, enhancement, and apparent diffusion coefficient were evaluated ...
TY - JOUR. T1 - Novel therapy for liver cancer. T2 - Direct intraarterial injection of a potent inhibitor of ATP production. AU - Geschwind, Jean Francois H.. AU - Ko, Young H.. AU - Torbenson, Michael S.. AU - Magee, Carolyn. AU - Pedersen, Peter L.. N1 - Copyright: Copyright 2008 Elsevier B.V., All rights reserved.. PY - 2002/7/15. Y1 - 2002/7/15. N2 - Most types of cancer are difficult to eradicate and some, like liver carcinomas, are almost always fatal. Significantly, we report here that direct intraarterial delivery of 3-bromopyruvate (3-BrPA), a potent inhibitor of cell ATP production, to liver-implanted rabbit tumors, inflicts a rapid, lethal blow to most cancer cells therein. Moreover, systemic delivery of 3-BrPA suppresses metastatic tumors that arise in the lungs. In both cases, there is no apparent harm to other organs or to the animals. Thus, intraarterial delivery of agents like 3-BrPA directly to the site of the primary tumor, followed by systemic delivery only when necessary, ...
TY - JOUR. T1 - Fabrication of radiopaque drug-eluting beads based on Lipiodol/biodegradable-polymer for image-guided transarterial chemoembolization of unresectable hepatocellular carcinoma. T2 - Fabrication of radiopaque DEBs by Lipiodol/biodegradable-polymer for TACE of HCC. AU - Okamoto, Yutaka. AU - Hasebe, Terumitsu. AU - Bito, Kenta. AU - Yano, Kosaku. AU - Matsumoto, Tomohiro. AU - Tomita, Kosuke. AU - Hotta, Atsushi. N1 - Funding Information: This work was supported in part by a Grant-in-Aid for Scientific Research (A) (No. 19H00831 to A. H.), by Grant-in-Aid for Challenging Exploratory Research (No. 19K22067 to A. H.), by a Grant-in-Aid for Scientific Research (B) (No. 18H01726 to T. H.), and by a Grant-in-Aid for JSPS Research Fellow (No. 18J13148 to K. B.) from the Japan Society for the Promotion of Science (JSPS: KAKENHI). It was also supported in part by AMED , Japan under Grant Number A306TS . Publisher Copyright: © 2020 Elsevier Ltd. PY - 2020/5. Y1 - 2020/5. N2 - New ...
Download Free Full-Text of an article EFFECT OF GUM ARABIC AND SOYBEAN SOLUBLE POLYSACCHARIDE AS COATING AGENTS ON OIL UPTAKE AND TEXTURE OF FRENCH FRIES USING RESPONSE SURFACE METHODOLOGY
Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma
RATIONALE: Drugs used in chemotherapy, such as liposomal doxorubicin, cisplatin, and mitomycin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. Chemoembolization kills tumor cells by blocking the blood flow to the tumor and keeping chemotherapy drugs near the tumor. Monoclonal antibodies, such as bevacizumab, can kill any tumor cells that are left after chemoembolization by blocking their ability to grow and spread.. PURPOSE: This randomized phase II trial is studying to see if chemoembolization followed by bevacizumab works better than chemoembolization alone in treating patients who have liver cancer that cannot be removed with surgery. ...
Number of Pages: 10 Iodized ethyl esters of poppy seed oil, ethyl esters of iodinated fatty acids of poppy seed oil. First published in the EFSA Journal: 7 March 2013 Adopted: 19 February 2013 Type: Statement Abstract: Following a request from the Eu .... ...
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Experimental Design: Thirty-two VX2 tumor-bearing New Zealand white rabbits underwent longitudinal imaging on clinical 3T-MRI and CT scanners before and up to 2 weeks after complete conventional transarterial chemoembolization (cTACE) using ethiodized oil (lipiodol) and doxorubicin. MR-spectroscopic imaging (MRSI) was employed for pHe mapping. Multiparametric MRI and CT were performed to quantify tumor enhancement, diffusion, and lipiodol coverage of the tumor posttherapy. In addition, incomplete cTACE with reduced chemoembolic doses was applied to mimic undertreatment and exploit pHe mapping to detect viable tumor residuals. Imaging findings were correlated with histopathologic markers indicative of metabolic state (HIF-1α, GLUT-1, and LAMP-2) and viability (proliferating cell nuclear antigen and terminal deoxynucleotidyl-transferase dUTP nick-end labeling). ...
The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy. ...
Angiographic imaging allows interventional radiologists during TACE therapy to selectively deliver anti-tumor substances through the arteries.
There is a person I know (not well) who has a very odd condition, a small brain tumor that is inoperable and causes extreme emotional agitation (much like bi-polar disorder x 1000). He is on a lot of meds just so he can function. Is it even prudent to recommend therapeudic iodine supplementation to someone who is taking so many medications (I can only imagine the kind of detox he will experience). Also, I doubt he will be able to stop the meds until the tumor has quit putting so much pressure on the brain so there is sort of a catch-22 going on. ...
Thyroid conditions, such as hypothyroidism, are a common complication of pregnancy, which has prompted scientific teams around the world to study iodine supplementation as a possible way to mitigate such risks.
Selection of 124 Messages Posted by breastcancerchoices.org from the forum Iodine Supplementation Support by VWT Team , Sorted by Date
Poppy has been one of the most important medicinal plant in humans until now. It and its products can not be manufactured synthetically. This study was conducted to determine the effects of poppy seed oil (PSO) supplementation ...
Care guide for Chemoembolization Cancer Therapy (Precare). Includes: possible causes, signs and symptoms, standard treatment options and means of care and support.
Updated 3 Dec 2013 Im in Frankfurt on a business trip and thanks to Peter, managed to steal some time to visit a German cancer clinic. The clinic is PraxisKlinik Siebenhuner and is on the outskirts of Frankfurt. Peter uses it for hyperthermia after a trans-arterial chemoembolisation session with Vogl. Its about a 30-minute taxi journey…
I am not allergic to iodine, I tested it on my skin plus my mother used to stick it on my skin a lot when I was young. I had/have undiagnosed pyroluria. This means B6 and zinc is bound up in heme and lost through urine and magnesium is not pushed into the cells efficiently, I would have had it all my life but I was coping with it. The extra demands with iodine pushed me over the top = severe palpitations = inability to access magnesium, Chronic detox = inability to break down B6 and therefore utilize zinc, extreme anxiety = pyroluria manifestation. I am willing to bet that most people ...
Objective The efficacy of combination transcatheter arterial chemoembolization(TACE) with subsequent percutaneous microwave coagulation therapy (PMCT)was assessed.Methods Eighteen patients with 28 tumors under TACE followed within 1~2 days by ultrasound guided PMCT,which were diagnosed by liver biopsy.Results Ninteen tumors measuring 5 cm in greatest dimension showed complete necrosis,5 of 9 tumors measuring ≥5 cm in greatest dimension showed complete necrosis.Conclusions Combination therapy with TACE and PMCT for liver tumor is effective.
Background: To compare the efficacy and safety of long- versus short-interval of transarterial chemoembolization (TACE) in unresectable hepatocellular carcinoma (HCC) patients.. Methods: This retrospective analysis enrolled 574 patients with unresectable HCC who underwent at least two sessions of TACE between January 2007 and December 2014. The patients were divided into a short-interval group (SIG) and a long-interval group (LIG) based on the median TACE interval of the first two sessions. Propensity score matching (PSM) identified 476 patients for a comparison of overall survival (OS) and safety.. Results: Before matching, the LIG had a longer OS than the SIG (Median: 12.1 vs. 8.7 months; P = 0.003). After matching, median OS in the SIG and LIG were 9.1 and 14.2 months (P , 0.001). The 1-, 2-, and 3-year survival rates were 37.5%, 17.1%, and 9.9% for SIG and 50.1%, 19.3%, and 11.6% for LIG, respectively. The TACE interval was an independent prognostic factor for OS. The LIG had a longer OS ...
2016 SIR Purpose To measure transarterial chemoembolization utilization and survival benefit among patients with hepatocellular carcinoma (HCC) in the Surveillance, Epidemiology, and End Results (SEER) patient population. Materials and Methods A retrospective study identified 37,832 patients with HCC diagnosed between 1991 and 2011. Survival was estimated by Kaplan-Meier method and compared by log-rank test. Propensity-score matching was used to address an imbalance of covariates. Results More than 75% of patients with HCC did not receive any HCC-directed treatment. Transarterial chemoembolization was the most common initial therapy (15.9%). Factors associated with the use of chemoembolization included younger age, more HCC risk factors, more comorbidities, higher socioeconomic status, intrahepatic tumor, unifocal tumor, vascular invasion, and smaller tumor size (all P < .001). Median survival was improved in patients treated with chemoembolization compared with those not treated with ...
TY - GEN. T1 - Multimodality therapy for cerebral vasospasm after SAH. T2 - Importance of intensive care and intraarterial injection of fasudil hydrochloride. AU - Ono, Shigeki. AU - Arimitsu, S.. AU - Ogawa, T.. AU - Onoda, K.. AU - Tokunaga, K.. AU - Sugiu, Kenji. AU - Date, Isao. PY - 2008. Y1 - 2008. N2 - Until now, no absolute therapy for cerebral vasospasm (VS) after subarachnoid haemorrhage (SAH) has been established. Here we examine the efficacy of intensive multimodality therapy, contrasting with the treatment in the non-multimodality period in our institute. For 10 years, a total of 108 patients who suffered subarachnoid haemorrhage (SAH) were divided into two groups. Group A patients are from a period of time when there was no particular standardized protocol for treating SAH, i.e. 1996-2000. Group B patients include the intensive care group for treating SAH, and we employed multimodality therapy on Group B by using intraventricular urokinase (UK) injection, lumbar (LD) or cisternal ...
TY - JOUR. T1 - Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization. AU - Choi, Seung Joon. AU - Kim, Jonghoon. AU - Seo, Jongbum. AU - Kim, Hyung Sik. AU - Lee, Jong Min. AU - Park, Hyunjin. PY - 2014/6. Y1 - 2014/6. N2 - Purpose: Accurate assessment of viability of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is important for therapy planning. The purpose of this study is to determine the diagnostic value of a novel image analysis method called parametric response mapping (PRM) in predicting viability of tumor in HCC treated with TACE for dynamic CT images. Methods: 35 patients who had 35 iodized-oil defect areas (IODAs) in HCCs treated with TACE were included in our study. These patients were divided into two groups, one group with viable tumors (n = 22) and the other group with non-viable tumors (n = 13) in the IODA. All patients ...
Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study
This study is investigating the efficacy and safety of sorafenib alone versus in combination with transarterial chemoembolization (TACE) (doxorubicin +
Cripto-1 may act as an independent predictor for prognosis in hepatocellular carcinoma (HCC). However, the function of Cripto-1 in HCC cells and its response to postoperative transarterial chemoembolization (TACE) in HCC patients remains unclearly. Up-regulated Cripto-1 expression boosted the ability of cell proliferation, migration and invasion in HCC cells in vitro. While opposite results were observed in HCC cells with down-regulated Cripto-1 expression. Cripto-1 expression was correlated with epithelial-mesenchymal transition (EMT) relevant biomarkers. Furthermore, in high Cripto-1 expression patients, those with adjuvant TACE had favorable TTR and OS times. On contrary, adjuvant TACE may promote tumor recurrence but had no influence on OS time in patients with low Cripto-1 expression. In different subgroups of vascular invasion, larger tumor size or liver cirrhosis, patients with adjuvant TACE had longer TTR and OS times than those without TACE in patients with high Cripto-1 expression,
AbstractWe aim to investigate the effects of postoperative adjuvant transarterial chemoembolization (TACE) on survival and recurrence in hepatocellular carcinoma (HCC) patients after radical resection. A total of 320 HCC patients underwent radical resection between January 2010 and January 2014 in Q
PURPOSE: Transarterial chemoembolisation (TACE) using irinotecan-eluting beads is an additional treatment option for colorectal cancer liver metastases (CRLM) patients that are not eligible for curative treatment approaches. This interim analysis focuses on feasibility of the planned statistical analysis regarding data distribution and completeness, treatment intention, safety and health-related quality of life (HRQOL) of the first 50 patients prospectively enrolled in the CIrse REgistry for LifePearl™ microspheres (CIREL), an observational multicentre study conducted across Europe.. METHODS: In total, 50 patients ≥ 18 years diagnosed with CRLM and decided to be treated with irinotecan-eluting LifePearl™ microspheres TACE (LP-irinotecan TACE) by a multidisciplinary tumour board. There were no further inclusion or exclusion criteria. The primary endpoint is the categorisation of treatment intention, and secondary endpoints presented in this interim analysis are safety, treatment ...
To determine the frequency and factors associated with the presence of intratumoral gas-containing areas in hepatocellular carcinoma (HCC) on computed tomography (CT) scans obtained 4-6 weeks after transarterial chemoembolization. From June 2010 to December 2011, 201 patients underwent 286 chemoe...
TY - JOUR. T1 - Regression of Hepatocellular Carcinoma With Right Atrial Extension After Sorafenib and Transarterial Chemoembolization. AU - Subramanian, Madhu. AU - Singal, Amit G.. AU - Yopp, Adam C.. PY - 2012/10/1. Y1 - 2012/10/1. UR - http://www.scopus.com/inward/record.url?scp=84866445106&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=84866445106&partnerID=8YFLogxK. U2 - 10.1016/j.cgh.2012.06.031. DO - 10.1016/j.cgh.2012.06.031. M3 - Article. C2 - 22813441. AN - SCOPUS:84866445106. VL - 10. SP - e83-e84. JO - Clinical Gastroenterology and Hepatology. JF - Clinical Gastroenterology and Hepatology. SN - 1542-3565. IS - 10. ER - ...
Transarterial chemoembolization may be offered as a main treatment for liver cancer or for people waiting for a transplant. Learn about TACE for liver cancer.
OP56 - A matched case-control study for the treatment of unresectable hepatocellular carcinoma (HCC): trans-arterial radioembolization (TARE) with 90Y glass microspheres plus sorafenib versus TARE ...
October 4, 2017-Guerbet, a company specializing in contrast products and solutions for medical imaging, recently announced that it has obtained European CE Mark approval for Vectorio, the companys conventional transarterial chemoembolization (cTACE) mixing and injection system.. According to Guerbet, Vectorio is a set of Lipiodol-resistant medical devices including syringes, stopcocks, and sampling devices. Vectorio is designed for mixing and delivering Lipiodol ultra fluid and anticancer drugs during cTACE procedures in adults with known, intermediate-stage hepatocellular carcinoma.. Designed and manufactured in France, the Vectorio device is being launched commercially this fall in European countries, where Lipiodol ultra fluid is registered for cTACE. Vectorio provides 24 hours of Lipiodol resistance. In addition, a three-way stopcock with four connections offers the possibility of on-table mixing, allowing interventional radiologists to remix without disconnection from the microcatheter, ...
TY - JOUR. T1 - An overview of loco-regional treatments in patients and mouse models for hepatocellular carcinoma. AU - Bimonte, Sabrina. AU - Barbieri, Antonio. AU - Palaia, Raffaele. AU - Leongito, Maddalena. AU - Albino, Vittorio. AU - Piccirillo, Mauro. AU - Arra, Claudio. AU - Izzo, Francesco. PY - 2015/3/9. Y1 - 2015/3/9. N2 - Hepatocellular carcinoma is a highly aggressive malignancy and is the third leading cause of cancer-related deaths worldwide. Although surgery is currently considered the most effective curative treatment for this type of cancer, it is note that most of patients have a poor prognosis due to chemioresistence and tumor recurrence. Loco-regional therapies, including radiofrequency ablation, surgical resection and transcatheter arterial chemoembolization play a major role in the clinical management of hepatocellular carcinoma. In order to improve the treatment outcome of patients diagnosed with this disease, several in vivo studies by using different techniques on cancer ...
Table 3: Comparison of Transcatheter Arterial Chemoembolization-Radiofrequency Ablation and Transcatheter Arterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma with Macrovascular Invasion Using Propensity Score Analysis: A Retrospective Cohort Study
TY - JOUR. T1 - Evaluation of posttreatment responseof hepatocellular carcinoma: comparisonof ultrasonography with second-generationultrasound contrast agent and multidetector CT. AU - Caruso, Giuseppe. AU - Meloni, Maria Franca. AU - Campisi, Antonella. AU - Salvaggio, Giuseppe. PY - 2010. Y1 - 2010. N2 - We evaluated the ability of one-month follow-up contrast-enhanced ultrasound (CEUS) with second-generationcontrast agent in monitoring radio frequencyablation (RFA) and transcatheter arterial chemoembolization(TACE) treatments of hepatocellular carcinoma(HCC). One-hundred forty-eight HCCs were studiedusing CEUS: 110 nodules were treated with RFA [41/110RFA were performed using a pretreatment and animmediate postablation evaluation using CEUS (group1); 69/110 using only US guidance (group 2)] and 38nodules treated with TACE. For statistical analysis,McNemar test was used. Overall complete response wasobserved in 107/148 nodules (92/110 treated with RFAand 15/38 with TACE). A better rate of ...
Transcatheter arterial chemoembolization (TACE) offers a survival benefit to patients with intermediate hepatocellular carcinoma (HCC). A widely accepted TACE regimen includes administration of doxoru
I m coming into this thread rather late, and I see you have a lot of good advice from many people with a lot of experience. I just want to tell you that we (husband and I) have been on Magnascent for about 3 months now. My husband did not experience the achy thyroid at all, but I did. Some people like to dive into the iodine supplementation, and it seems to work well for them. After my thyroid started aching, I decided to treat that as a signal from my body to take it slower. I took a week off from iodine supplementation, then started back slowly, with 2 drops a day the first week. T ...
In this study, the mean OS for all patients was 80.7 ± 5.6 months, and the 1-, 3-, and 5-year median OS rates were 88.1%, 64.8%, and 49.9%, respectively. Recent studies in which patients with early HCC or HCC , 4 cm received TACE as the initial treatment modality have shown that the 1-, 3-, and 5-year survival rates were 89% to 100%, 63% to 81%, and 43% to 52%, respectively [33-37]. The results of our study are in line with those of these studies. Another study investigated the long-term survival of patients with HCC who met the Milan criteria and underwent RFA (n = 315) or TACE (n = 215) as an initial treatment. The two groups did not show any significant differences in terms of long-term survival rates (the 1-, 3-, and 5-year survival rates were 85%, 60%, and 41% for RFA, and 86%, 55%, and 36% for TACE, respectively) [33]. Recently, Kim et al. [7] reported that TACE can be a viable alternative treatment modality for small HCCs (, 2 cm) when RFA is not indicated, although RFA showed better ...
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
The objective of this study is to evaluate the safety and efficacy of Irinotecan Bead in the neoadjuvant treatment (i.e. the Irinotecan Bead is administ
If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team ...
THURSDAY, May 18, 2017 (HealthDay News) -- A 100-year-old medical treatment could help infertile women get pregnant without undergoing pricey in vitro fertilization (IVF), a new study suggests.. The method was first used in 1917 and involves flushing a womans fallopian tubes with an iodized poppy seed oil.. Over the past century, pregnancy rates among infertile women reportedly increased after their tubes had been flushed with either water or oil during a dye test of the fallopian tubes under X-ray, explained study lead researcher Ben Mol. Hes with the University of Adelaide in Australia.. Until now, it has been unclear whether the type of solution used in the procedure was influencing the change in fertility, Mol said in a university news release.. Our results have been even more exciting than we could have predicted, helping to confirm that an age-old medical technique still has an important place in modern medicine, he added.. This study included more than 1,100 women being treated ...
title: Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma, doi: 10.1016/j.jhep.2015.01.022, category: Article
This ultra-fluid iced chocolate, slightly satin tunic dress is ideal for summer evenings. It can be worn with heels or in more casual fashion with sandals or sneakers. Offered in one size, it is suitable for all body types. A scalloped collar highlights the port of the head. A line of high-end wax embellishes with gold or silver throughout the length of the dress. This line can be worn in front or behind according to your inspiration of the moment, it gives this dress a discreet, chic, elegant and original charm.. Product made in France.. Sold out. ...
Iodine Global Network is a non-profit, non-government organization for the sustainable elimination of iodine deficiency worldwide.
Vascular Interventional Physicians is an outpatient-style clinic offering convenience and choice to physicians, and to patients who refer themselves.
요측전완유리피판의 결손 부위를 재건하는 국내 보고로는 Tae 등[13]이 자측(ulnar) 전진 피판으로 전완 결손 부위를 재건하였고, Jeong 등[14]은 전층 피부 이식술이 부분층 피부 이식술보다 공여부의 합병증이 적고 미용적으로 더 좋다고 하였다. 국외에서는 그동안 많은 연구들이 있었는데, 최근 Pabst 등[3]은 1982년부터 2017년까지 1056개의 논문을 검색하여 메타분석을 시행하였으며, 그 결과는 아래에 기술하였다.. 부분층 이식술은 가장 흔한 방법으로서, 주로 앞쪽 대퇴부에서 0.2~0.5 mm의 두께로 얻는다. 간단하고, 신뢰할 만하며, 얻을 수 있는 부위도 대부분 제한이 없어, 연장된 요측전완 결손 부위에 사용될 수 있다는 장점이 있다. 반면 단점으로는 기능상 혹은 미용상 결과가 좋지 않다는 것인데, 특히 전완부 결손의 부피가 큰 경우에 두드러진다. 때로 피부 ...